Sanvito W L, Tilbery C P
Arq Neuropsiquiatr. 1980 Dec;38(4):375-84. doi: 10.1590/s0004-282x1980000400007.
The clinical and therapeutic aspects in 26 patients with cluster headache are reported. The patient's age ranged between 14 and 60 years old (average 31.5 years); 22 were male and 4 female. The patients constituted a consecutive series of typical cases (only one was a chronic cluster) with regular headache attacks; in 69.2 per cent of the cases there were associated symptoms and signs (ipsilateral lacrimation, stuffiness of the ipsilateral nostril and Horner's syndrome). In seven patients the cluster was induced by alcohol ingestion (during an active cluster period) and a cluster attack was reproduced by isosorbitol dinitrate (vasodilator drug) in one patient. All patients received orally either methysergide maleate, prednisone or both. The first drug used, in 20 patients, was methysergide maleate in a dosage of 3--6 mg daily over a four weeks period. Eight patients received prednisone only, which presented side-effects or no improvement with methysergide, in a dosage of 40--60 mg daily and tapered off over a period of four weeks. Methysergide maleate and prednisone were given to 11 patients in association, because of moderate effect of the first drug. The clinical effect of the treatment was judged according to the following three categories: freedom from the attacks; slight improvement of the attacks; no improvement of the attacks. In 57.6 per cent of the cases (15 patients) there was freedom of the attacks, in 30.7 per cent of the cases (8 patients) there was a slight improvement and in 3 patients there was no improvement.
报告了26例丛集性头痛患者的临床和治疗情况。患者年龄在14至60岁之间(平均31.5岁);男性22例,女性4例。这些患者构成了一系列连续的典型病例(仅1例为慢性丛集性头痛),头痛发作规律;69.2%的病例伴有相关症状和体征(同侧流泪、同侧鼻塞和霍纳综合征)。7例患者的丛集性头痛由饮酒诱发(在丛集性头痛发作活跃期),1例患者静脉注射硝酸异山梨酯(血管扩张剂)诱发了丛集性头痛发作。所有患者口服马来酸麦角新碱、泼尼松或两者联用。20例患者首先使用的药物是马来酸麦角新碱,剂量为每日3 - 6毫克,持续4周。8例患者仅接受泼尼松治疗,这些患者出现了副作用或使用马来酸麦角新碱后无改善,剂量为每日40 - 60毫克,4周内逐渐减量。11例患者联合使用马来酸麦角新碱和泼尼松,因为第一种药物效果中等。根据以下三类判断治疗的临床效果:无发作;发作稍有改善;发作无改善。57.6%的病例(15例患者)无发作,30.7%的病例(8例患者)稍有改善,3例患者无改善。